[A beta blockader-diuretic combination in long-term anti-hypertensive therapy. Undesirable effects on blood potassium].
Severin
E
E
Mladovan
G
G
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D002752:Chlorthalidone / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D006973:Hypertension / Q000188:drug therapy; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D006852:Hydrochlorothiazide; D002752:Chlorthalidone
Associazione beta-bloccante-diuretico nella terapia anti-ipertensiva a lungo termine. Effetti indesiderati sulla potassiemia.